Actively Recruiting
Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy
Led by Centre Hospitalier St Anne · Updated on 2025-10-01
80
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
During a cessation therapy for tobacco or cannabis, sleep disorders are one of the main risk factors of relapse, and a symptom of substance withdrawing. In this study, we make the hypothesis that identifying and managing potential sleep disorders during cessation treatment may contribute to maintain tobacco / cannabis abstinence on the long-term. To evaluate the impact of such intervention, we will conduct a randomised pilot study among patients consulting at two addiction prevention and care centres, for smoking or cannabis use cessation treatment. Control group will benefit of usual care (a multidisciplinary care with individual and group therapies); intervention group will benefit in addition of a systematic screening of sleep disorders, and in case of a diagnosed alteration, they will be addressed to the Chronos centre, for specific care to help them manage and reduce the consequences of their sleep disorders. Participants will be followed over a 6-month period, with visits at 1 and 3 months, to monitor smoking or cannabis cessation, and other criteria associated with their substance use or sleep.
CONDITIONS
Official Title
Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years old
- Presenting at participating addiction treatment centers for smoking or cannabis cessation therapy
- Agree to participate in the study
- Affiliated with the French health insurance system
You will not qualify if you...
- Currently hospitalized during cessation therapy
- Receiving treatment for sleep disorders
- Participating in another study
- Diagnosed with psychotic disorders according to DSM-5
- Unwilling to receive additional sleep disorder intervention if assigned to the intervention group
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
GHU Paris Psychiatrie et Neurosciences
Paris, Île-de-France Region, France, 75014
Actively Recruiting
Research Team
A
Anne PEROZZIELLO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here